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Figure 2. The subform utilized for entering and viewing CIBMTR-reported data is similar to the CIBMTR Post-TED 2450.
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while simultaneously reporting within FormsNet3. Dynamic
queries were built for all commonly requested subsets of
data, such as transplant volumes, mortality, engraftment,
GVHD, etc.
Conclusion: Compiling data for clinician requests and
re-certiﬁcations, which used to take days, now takes only
minutes. Patient-speciﬁc reports were built that allow users
to instantly fax a request for information to external
providers with one click of a button, which decreased the
time spent on this activity alone by more than 75%. Our BMT
program has found Access to be a dynamic, cost-effective
and resourceful solution to meeting current program quality
improvement (QI) data needs and fulﬁlling federal reporting
requirements.
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Addressing the Need for Standardized Adverse Event (AE)
Documentation within the Electronic Medical Record
(EMR)
Lindsay Dozeman 1, Allyson Schultz 2, Annick Tricot 2,
Kalyan Nadiminti 3. 1 Blood and Marrow Transplant, The
University of Iowa Hospitals and Clinics, Iowa City, IA; 2 Clinical
Trials Support Core, University of Iowa Hospitals, Iowa City, IA;
3 Adult Blood and Marrow Transplant Unit, University of Iowa
Hospitals and Clinics, Iowa City, IA
Background: Accurate reporting of adverse events (AEs)
facilitates analyses of new and approved therapies and is a
federal requirement for clinical research. Healthcare
professionals utilize the Common Terminology Criteria for
Adverse Events (CTCAE) for this reporting. Our group
reviewed the documentation within our hospital's EMR
Epic for a subset of over 100 transplants performed in
2012-2013 and collected data for toxicities meeting grades 3
or higher into a shared project-speciﬁc Access database
which is tied to the program BMT database. We then
imported the CTCAE from a spreadsheet into drop down
menus to decrease the likelihood of entry errors and tostandardize the data at the time of ﬁrst entry. As we
reviewed the documentation in Epic, it became clear that a
lack of standardized terminology made it difﬁcult for the
consistent and accurate documentation of this data within
the medical records.
Conclusion: As a result of our experience with our data
project, current efforts are underway to have a dynamic and
user-friendly CTCAE template with drop down menus
and descriptive grading criteria built into Epic for AE
documentation by the clinical team. We anticipate that the
CTCAE documentation capability currently being built will
standardize and improve the documentation of this
important data. In addition, because this templatewill utilize
discrete ﬁelds, the BMT program will be able to run reports
on documented toxicities with ease, thereby saving staff time
and resources by eliminating the need for other team
members to re-enter Epic and search each record for this
data.373
Outpatient Transplant Management Affects ANC Recovery
Data Endpoint
Rebecca Evans, Jessica Matthias, Barbara Kutchmarek. Blood
and Bone Marrow Transplant Program, University of Wisconsin
Hospital and Clinics, Madison, WI
We noted an increase in number of days to ANC recovery
in the autologous transplant patient population. In order
to determine the cause, we developed an audit plan
comparing time to ANC recovery in autologous trans-
plants performed in CY 2003 (n¼33) and CY 2013
(n¼72). A change in clinical practice was discovered. In
2003, the majority of patients were inpatient at the time
of the ﬁrst lab value demonstrating ANC 0.5 x 109/L. If
they were discharged prior to ANC  0.5 x109/L, patients
returned for daily lab draws until the ﬁrst of the three
consecutive lab value of ANC  0.5 x109/L was reached.
In 2013, many patients were discharged prior to ANC
recovery. None of these patients discharged prior to ANC
Figure 1. Our project-speciﬁc database utilized CTCAE drop down menus to improve the collection of adverse event data. This capability will be enhanced and built
into our EMR, Epic.
Table 1
ANC Recovery Comparison
2003
(n[ 33)
2013
(n[ 72)
ANC Recovery Inpatient 26 (79%) 45 (63%)
ANC Recovery Post-Discharge 7 (21%) 27 (38%)
Daily Labs Drawn Until ANC
 0.5 x109/L Post-Discharge
5 (15%) 0
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this subset, we discovered a gap in the number of days
between their last lab showing ANC < 0.5 x109/L and
their ﬁrst lab showing ANC  0.5 x109/L. The upward
trend in days to ANC recovery was not because of
delayed ANC recovery, but due to increasing days be-
tween lab draws.ANC  0.5 x109/L With Non-Daily
Lab Draws
2 (6%) 27 (38%)
ANC  0.5 x109/L With Daily Lab Draws 31 (94%) 45 (63%)
Days between last lab ANC
< 0.5 x109/L <500 and ﬁrst
lab ANC  0.5 x109/L
1-2 1-19
Table 2
Days to ANC Recovery
2003
(n[33)
2013
(n[72)
2013 Daily
Labs (n[45)
2013 Non-Daily
Labs (n[27)
Average 11 15 12 21
Median 11 13 11 20
Range 9-15 10-42 10-16 15-42
We propose adding a reporting ﬁeld to capture date of last lab showing ANC
< 0.5 x109/L. This would help identify when a delay in lab draw occurred
leading to the realization that ANC recovery may have been earlier than
indicated.374
Monthly Internal Assessments Result in Successful
CIBMTR Audit
Nicolette Maria Minas, Kathleen Ruehle. Greenebaum Cancer
Center, University of Maryland, Baltimore, MD
Background: The University of Maryland Blood and
Marrow Transplant (BMT) team has a reputation of estab-
lishing a culture of continuous quality improvement to
assure the utmost accuracy of CIBMTR data. In early 2012,
Minas and Ruehle reported the signiﬁcance of auditing 10
commonly used data points. In early 2013, Minas and
Ruehle set out to further improve CIBMTR data accuracy by
combining their original set of commonly used data points
with 19 additional ones. In early 2014, Minas and Ruehle
developed a survey to explore the internal assessment
audit activities utilized by 137 CIBMTR afﬁliated transplant
centers.
Methods: To manage any current or possible data quality
issues at transplant centers CIBMTR performs an audit every
four years. CIBMTR randomly selected 16 University ofMaryland BMT transplants for audit in 2014. To be eligible for
audit, one of the following form combinations must be
submitted to the outcomes registry: Pre-Transplant Essential
